Male breast cancer (MBC) is an uncommon and poorly understood disease. Recent
molecular studies have shown important differences from female breast cancer which are …

Simple Summary Male breast cancer (MBC) is a rare disease. Genetic factors predispose to
male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic …

Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Simple Summary Male breast cancer is a rare disease, representing around 0.5% of the
malignances in men. Although they receive the same treatment as women with breast …

Male breast cancer (MaleBC) is a rare disease, accounting for< 1% of all male tumors.
During the last few years, there has been an increase in the incidence of this disease, along …

Male breast cancer (MBC) is a rare tumor, accounting for less than 1% of all breast cancers.
In MBC, genetic predisposition plays an important role; however, only a few studies have …

Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast
malignancies. Therefore, clinical management of MBC is currently guided by research on …

Purpose: Male breast cancer is rare, and its genomic landscape has yet to be fully
characterized. Lacking studies in men, treatment of males with breast cancer is extrapolated …

Background: Male breast cancer (MBC) is still poorly understood with a large proportion
arising in families with a history of breast cancer. Genomic studies have focused on germline …

Background Male breast cancer (MBC) is an uncommon and relatively uncharacterised
disease accounting for< 1% of all breast cancers. A significant proportion occurs in families …